132 related articles for article (PubMed ID: 12440275)
1. Enzyme replacement therapy for Gaucher Disease: the only experience in Malaysia.
Chan LL; Lin HP
Med J Malaysia; 2002 Sep; 57(3):348-52. PubMed ID: 12440275
[TBL] [Abstract][Full Text] [Related]
2. Enzyme replacement therapy in pediatric patients with Gaucher disease: what should we use as maintenance dosage?
Brunel-Guitton C; Rivard GE; Galipeau J; Alos N; Miron MC; Therrien R; Mitchell G; Lapierre G; Lambert M
Mol Genet Metab; 2009 Feb; 96(2):73-6. PubMed ID: 19083253
[TBL] [Abstract][Full Text] [Related]
3. [A retrospective study on enzyme replacement therapy in patients with Gaucher disease].
Duan YL; Zhang YH; Zang Y; Shi HP; Zhang WM; Hu YM
Zhonghua Er Ke Za Zhi; 2006 Sep; 44(9):653-6. PubMed ID: 17217655
[TBL] [Abstract][Full Text] [Related]
4. [Enzyme replacement therapy for Gaucher paediatric disease: the only Tunisian experience].
Ben Turkia H; Azzouz H; Tebib N; Abdelmoula MS; Ben Chehida A; Hlel Y; Caillaud C; Sahli H; Ben Dridi MF
Tunis Med; 2009 May; 87(5):344-8. PubMed ID: 19927767
[TBL] [Abstract][Full Text] [Related]
5. Outcome of enzyme replacement therapy in Turkish patients with Gaucher disease: does late intervention affect the response?
Arikan-Ayyildiz Z; Yüce A; Emre S; Baysoy G; Saltik-Temizel IN; Gürakan F
Turk J Pediatr; 2011; 53(5):499-507. PubMed ID: 22272449
[TBL] [Abstract][Full Text] [Related]
6. Enzyme replacement therapy with imiglucerase in a Taiwanese child with type 1 Gaucher disease.
Lin HY; Lin SP; Chuang CK; Wraith JE
J Chin Med Assoc; 2006 May; 69(5):228-32. PubMed ID: 16835986
[TBL] [Abstract][Full Text] [Related]
7. Enzyme replacement therapy and bony changes in Egyptian paediatric Gaucher disease patients.
El-Beshlawy A; Ragab L; Youssry I; Yakout K; El-Kiki H; Eid K; Mansour IM; Abd El-Hamid S; Yang M; Mistry PK
J Inherit Metab Dis; 2006 Feb; 29(1):92-8. PubMed ID: 16601874
[TBL] [Abstract][Full Text] [Related]
8. [Gaucher disease: enzyme replacement treatment initiated at pediatric age; 20-year experience].
Vitoria Miñana I; Dalmau Serra J
An Pediatr (Barc); 2016 Jun; 84(6):343-6. PubMed ID: 26724255
[No Abstract] [Full Text] [Related]
9. Immunoglobulin abnormalities and effects of enzyme replacement therapy in children with Gaucher disease.
Arıkan-Ayyıldız Z; Yuce A; Uslu-Kızılkan N; Demir H; Gurakan F
Pediatr Blood Cancer; 2011 Apr; 56(4):664-6. PubMed ID: 21298757
[TBL] [Abstract][Full Text] [Related]
10. The effect of enzyme replacement therapy on bone crisis and bone pain in patients with type 1 Gaucher disease.
Charrow J; Dulisse B; Grabowski GA; Weinreb NJ
Clin Genet; 2007 Mar; 71(3):205-11. PubMed ID: 17309642
[TBL] [Abstract][Full Text] [Related]
11. [Gaucher disease: MR evaluation of bone marrow features during treatment with enzyme replacement].
Poll LW; vom Dahl S; Koch JA; Börner D; Willers R; Cohnen M; Jung G; Scherer A; Niederau C; Häussinger D; Mödder U
Rofo; 2001 Oct; 173(10):931-7. PubMed ID: 11588682
[TBL] [Abstract][Full Text] [Related]
12. Histologic findings of femoral heads from patients with Gaucher disease treated with enzyme replacement.
Lebel E; Elstein D; Peleg A; Reinus C; Zimran A; Amir G
Am J Clin Pathol; 2013 Jul; 140(1):91-6. PubMed ID: 23765538
[TBL] [Abstract][Full Text] [Related]
13. [Enzyme replacement therapy in Gaucher disease: monitoring visceral and bone changes with MRI].
Tóth J; Szücs FZ; Benkö K; Maródi L
Orv Hetil; 2003 Apr; 144(16):749-55. PubMed ID: 12778625
[TBL] [Abstract][Full Text] [Related]
14. [French results of enzyme replacement therapy in Gaucher's disease].
Schaison G; Caubel I; Belmatoug N; Billette de Villemeur T; Saudubray JM
Bull Acad Natl Med; 2002; 186(5):851-61; discussion 861-3. PubMed ID: 12412377
[TBL] [Abstract][Full Text] [Related]
15. Type I Gaucher disease in children with and without enzyme therapy.
Dweck A; Abrahamov A; Hadas-Halpern I; Bdolach-Avram T; Zimran A; Elstein D
Pediatr Hematol Oncol; 2002 Sep; 19(6):389-97. PubMed ID: 12186361
[TBL] [Abstract][Full Text] [Related]
16. A cross-sectional, mono-centric pilot study of insulin resistance in enzyme replacement therapy patients with Gaucher type I without overweight.
Ucar SK; Coker M; Argin M; Akman S; Kara S; Simsek DG; Darcan S
Mol Genet Metab; 2009 Jan; 96(1):50-1. PubMed ID: 19006678
[TBL] [Abstract][Full Text] [Related]
17. Cognitive outcome in treated patients with chronic neuronopathic Gaucher disease.
Goker-Alpan O; Wiggs EA; Eblan MJ; Benko W; Ziegler SG; Sidransky E; Schiffmann R
J Pediatr; 2008 Jul; 153(1):89-94. PubMed ID: 18571543
[TBL] [Abstract][Full Text] [Related]
18. Enzyme replacement therapy for Gaucher disease in Australia.
Goldblatt J; Szer J; Fletcher JM; McGill J; Rowell JA; Wilson M
Intern Med J; 2005 Mar; 35(3):156-61. PubMed ID: 15737135
[TBL] [Abstract][Full Text] [Related]
19. Bone complications in children with Gaucher disease.
Bembi B; Ciana G; Mengel E; Terk MR; Martini C; Wenstrup RJ
Br J Radiol; 2002; 75 Suppl 1():A37-44. PubMed ID: 12036831
[TBL] [Abstract][Full Text] [Related]
20. Enzyme replacement therapy in a child with Gaucher disease.
Masood Y; Ali AS
J Coll Physicians Surg Pak; 2006 Dec; 16(12):786-8. PubMed ID: 17125641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
